English | Español

Novartis
Amanda Rupp | Aug 31, 2016

Sandoz's Erelzi gains FDA approval for multiple inflammatory diseases
Jamie Barrand | Feb 20, 2016

Novartis' new AML therapy granted FDA Breakthrough Designation
Jamie Barrand | Feb 20, 2016

Alcon, Transcend Medical partner on glaucoma therapy project
Jamie Barrand | Feb 13, 2016

Sandoz acquires infliximab inhibitor treatment from Pfizer
Kasey Schefflin- Emrich | Jan 28, 2016

FDA approves Cosentyx as treatment for two inflammatory conditions

Trending
Patient Daily | Oct 22, 2025

Chronic Care Policy Alliance backs federal legislation to reform the 340B Drug Pricing Program
Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
Patient Daily | Oct 21, 2025

Gulf Coast Breathe Free Physician Assistant on sinus issues: ‘Certain things like dairy seem to increase mucus production’